Why blood pressure, cholesterol, and blood sugar are some of the most important — and most modifiable — influences on your long-term brain health.
The short version
1What harms your blood vessels tends to harm your brain. Most of the cardiovascular risk factors that affect your heart also affect your risk of dementia.
2The 2024 Lancet Commission links high midlife LDL cholesterol to about 7% of dementia cases, with hypertension, diabetes, and obesity adding more on top.
3In the SPRINT MIND trial, intensive blood pressure control was associated with about 19% lower risk of mild cognitive impairment — though the effect on dementia itself was not statistically significant.
4Midlife — roughly your 40s and 50s — appears to be the window where managing these numbers matters most for the brain.
Is heart health really brain health? In large part, yes. The blood vessels that feed your heart and the blood vessels that feed your brain are part of the same system, and the same things that damage one tend to damage the other. That is why the 2024 Lancet Commission on dementia — the most comprehensive framework in the field — places several cardiovascular and metabolic factors among the 14 modifiable risk factors that together account for roughly 45% of dementia cases worldwide. The encouraging part is that these are among the most measurable and treatable risks on the entire list. You can know your numbers, and you can often change them.
The heart–brain connection
Your brain is one of the most blood-hungry organs in your body, consuming a large share of the oxygen and glucose your circulation delivers. It depends on a dense network of small, delicate blood vessels. When those vessels are damaged — by years of high blood pressure, high cholesterol, or high blood sugar — the brain's supply lines suffer.
The cardiovascular risk factors that affect your brain
The 2024 Lancet Commission expresses each risk factor as the percentage of dementia cases that could, in principle, be avoided if that factor were eliminated across the population. Here is how the cardiovascular and metabolic factors stack up.
7%
of dementia cases attributable to high midlife LDL cholesterol
2024 Lancet Commission
A note on adding these up
It is tempting to sum these percentages, but the Commission is explicit that the figures are not strictly additive. The factors overlap heavily — high blood pressure, diabetes, high cholesterol, and obesity tend to cluster together as part of metabolic syndrome — so the combined effect is smaller than 7 + 2 + 2 + 1. Think of them as one interconnected cardiovascular story, not four separate boxes to tick.
What the strongest evidence shows
The landmark trial in this area is SPRINT MIND, published in JAMA in 2019. It randomly assigned 9,361 adults aged 50 and older with high blood pressure and elevated cardiovascular risk to either intensive blood pressure control (a systolic target below 120 mmHg) or standard control (below 140 mmHg).
19%
lower risk of mild cognitive impairment with intensive blood pressure control
SPRINT MIND, JAMA 2019
The intensive group had about 19% lower risk of developing mild cognitive impairment (MCI), a well-established precursor to dementia — the first time a randomized trial showed that an intervention could reduce MCI. A later follow-up published in Neurology in 2025 reported that the benefit persisted for years after the intensive treatment ended.
What this trial did and didn't prove
Honesty matters on a topic this consequential. The 19% figure applies to mild cognitive impairment, which was a secondary outcome. The trial's primary outcome — probable dementia itself — did not reach statistical significance, most likely because the study was stopped early (after about 3.3 years) for cardiovascular benefit, leaving too little time for dementia to develop and be counted. SPRINT MIND also excluded people with diabetes or prior stroke, so its results don't automatically extend to everyone. The honest reading: intensive blood pressure control is associated with meaningfully less cognitive impairment, but we cannot yet say it "prevents dementia."
When it matters most: the midlife window
A recurring theme in the Lancet framework is timing. Most of the cardiovascular and metabolic factors — hypertension, high LDL, diabetes, obesity — exert their greatest influence in midlife, roughly your 40s and 50s, even though the dementia they're linked to may not appear until decades later.
The practical implication
The numbers you set in your 40s and 50s may shape your brain in your 70s. That's not cause for alarm — it's leverage. A blood pressure reading, a cholesterol panel, and a blood sugar check are simple, and acting on them early is one of the most evidence-aligned things you can do for your future brain.
What you can do
You don't need to treat brain health and heart health as separate projects, because they're not.
What's good for your heart is, to a remarkable degree, good for your brain. High cholesterol, high blood pressure, diabetes, and excess weight are among the most modifiable dementia risk factors identified by the 2024 Lancet Commission — and unlike many risks, they can be measured at a routine check-up and acted on. The evidence is strongest that managing these numbers reduces cognitive impairment; it is suggestive, though not yet proven, that doing so prevents dementia outright. Either way, the case for knowing your numbers in midlife and acting on them is about as solid as prevention evidence gets.
Where do you stand across all 14 risk factors?
Take the Brain Health Quiz to get your personalized profile across all five domains — with specific action steps for your highest-priority areas. Takes about 5 minutes.
1. Livingston, G., et al. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet, 404(10452), 572–628.
2. Williamson, J.D., et al. (2019). Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial (SPRINT MIND). JAMA, 321(6), 553–561.
3. Nasrallah, I.M., et al. (2019). Association of intensive vs standard blood pressure control with cerebral white matter lesions. JAMA, 322(6), 524–534.
4. SPRINT MIND extended follow-up (2025). Neurology, Wake Forest University School of Medicine. [Confirm exact citation/URL before publishing.]
Medical disclaimer: This content is for educational purposes and is not medical advice. Consult a healthcare professional before making changes to your health routine.
Last reviewed: June 2026
This site uses cookies for analytics to understand how visitors engage with our content.
Privacy policy